Bridger Management Buys These 5 Stocks in Third Quarter

Wall St. Watchdog reveals information regarding significant increase in shares for Bridger Management’s holdings on the quarter ending September 30th, 2011. The firm is bullish on these stocks:

  • Bp Plc (NYSE:BP): On 06/30/2011, Bridger Management reported holding 0 shares. On 09/30/2011, Bridger Management reported holding 575,000 shares. The net increase in shares for this position is 575,000. About Company: BP plc is an oil and petrochemicals company. The Company explores for and produces oil and natural gas, refines, markets, and supplies petroleum products, generates solar energy, and manufactures and markets chemicals. BP’s chemicals include terephthalic acid, acetic acid, acrylonitrile, ethylene and polyethylene.
  • Wright Medical Group Inc. (NASDAQ:WMGI): On 06/30/2011, Bridger Management reported holding 0 shares. On 09/30/2011, Bridger Management reported holding 1,225,000 shares. The net increase in shares for this position is 1,225,000. About Company: Wright Medical Group, Inc., an orthopedic device company, specializes in the design, manufacture, and marketing of reconstructive joint devices and bio-orthopedic materials. The Company’s joint devices are used to replace knee, hip, and other joints that have deteriorated through disease or injury.
  • Pharmasset Inc. (NASDAQ:VRUS): On 06/30/2011, Bridger Management reported holding 0 shares. On 09/30/2011, Bridger Management reported holding 290,000 shares. The net increase in shares for this position is 290,000. About Company: Pharmasset, Inc. is a pharmaceutical company. The Company develops oral therapeutics for the human immunodeficiency virus (HIV), hepatitis B (HBV), and hepatitis C (HCV).
  • Charles River Laboratories International Inc. (NYSE:CRL): On 06/30/2011, Bridger Management reported holding 0 shares. On 09/30/2011, Bridger Management reported holding 969,850 shares. The net increase in shares for this position is 969,850. About Company: Charles River Laboratories International, Inc. provides research tools and support services that enable drug discovery and development. The Company provides the animal research models required in research and development for new drugs, devices, and therapies. Charles River’s customers include pharmaceutical and biotechnology companies, hospitals, and academic institutions.
  • Mako Surgical Corp. (NASDAQ:MAKO): On 06/30/2011, Bridger Management reported holding 0 shares. On 09/30/2011, Bridger Management reported holding 400,000 shares. The net increase in shares for this position is 400,000. About Company: MAKO Surgical Corp. is a medical device company. The Company offers robotic-ARM solutions and implants for minimally invasive orthopedic knee procedures.

(Note: Data regarding Bridger Management’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>